Monitoring of biomarkers in heart failure.

Abstract

The role of biomarkers is increasingly recognized in heart failure (HF) management, for diagnosis, prognostication, and screening of high-risk patients. Beyond natriuretic peptides and troponins, the utility of novel, emerging biomarkers is less established. This document reflects the key points of a Heart Failure Association of the European Society of Cardiology (ESC) consensus meeting on biomarker monitoring in HF.

• Authors: Ilaria Spoletini, Andrew J S Coats, Michele Senni, Giuseppe M C Rosano
• Journal: European heart journal supplements : journal of the European Society of Cardiology (Eur Heart J Suppl) Vol. 21 Issue Suppl M Pg. M5-M8 (Dec 2019) ISSN: 1520-765X [Print] England
• PMID: 31908607 (Publication Type: Journal Article)
• Copyright: Published on behalf of the European Society of Cardiology. © The Author(s) 2019.